Literature DB >> 4829543

Increase of hexobarbital sleeping time and inhibition of drug metabolism by the major metabolite of diphenylhydantoin.

S A Stavchansky, W C Lubawy, H B Kostenbauder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4829543     DOI： 10.1016/0024-3205(74)90164-7

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  3 in total

Review 1.  The use of kinetic-dynamic interactions in the evaluation of drugs.

Authors:  D B Campbell
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.

Authors:  Christopher Louizos; Jaime A Yáñez; M Laird Forrest; Neal M Davies
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

3.  Effect of diphenylhydantoin and its main hydroxylated metabolite on the pharmacokinetics and the urinary and biliary excretion of phenobarbital and its p-hydroxy metabolite.

Authors:  F Sarhan; J M Engasser; A M Batt; J Magdalou; G Siest
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.